Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus

Affiliations

• ¹ Previse, Baltimore, Maryland, USA.
• ² Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ³ Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁴ Division of Biostatistics, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁵ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
• ⁶ Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.
• ⁷ Allegheny Health Network Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA.
• ⁸ Esophageal Institute, Department of Surgery, Allegheny Health Network, Pittsburgh, PA, United States.
• ⁹ Department of Surgery, Drexel University, Philadelphia, PA, United States.
• ¹⁰ Capital Digestive Care, Chevy Chase, Maryland, USA.
• ¹¹ Department of Gastroenterology & Hepatology, Erasmus MC University Medical Center, 3015 GD Rotterdam, The Netherlands.
• ¹² Research Tissue Biorepository Core Facility, University of Connecticut, CT, USA.
• ¹³ Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.